Mosaic’s use of advanced computational methods, while combining mining of large datasets with experimental approaches to identify and develop novel targeted therapies, completely reinvents the traditional approach to target and drug discovery
Mosaic Therapeutics has raised €25M across 1 funding round from 2 investors, most recently a Series A round in Apr 2023. Based in Cambridge, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-04-06 | Series A | €25M |
| Cambridge Innovation Capital,Syncona Investment Management |
| View deal → |
